Zydus Wellness Reports 14.4% Rise in Q4 FY25 Net Profit to ₹171.9 Crore

Zydus Wellness Ltd., a prominent player in India’s fast-moving consumer goods (FMCG) sector, announced a 14.4% increase in net profit for the fourth quarter of fiscal year 2024–25, reaching ₹171.9 crore. This growth is attributed to robust performances across its food, nutrition, and personal care segments.

Financial Highlights

• Net Profit: ₹171.9 crore, up 14.4% year-on-year
• Revenue: Significant growth driven by strong demand in key product categories
• Operational Efficiency: Improved margins reflecting effective cost management

The company’s flagship brands—Glucon-D, Sugar Free, Complan, Nycil, and Everyuth—have maintained strong market positions, contributing to the overall financial performance.

Company Overview

Headquartered in Ahmedabad, Zydus Wellness operates three manufacturing facilities located in Gujarat and Sikkim. As a subsidiary of Zydus Lifesciences (formerly Cadila Healthcare), the company continues to focus on innovation and expanding its product portfolio to meet evolving consumer needs.

Outlook

With a solid foundation and a diverse range of well-established brands, Zydus Wellness is poised to sustain its growth trajectory. The company aims to leverage its market presence and operational strengths to navigate the competitive FMCG landscape effectively.